1. Current status of intratumoral therapy for glioblastoma

   • Ankit I. Mehta
   • Andreas Linninger
   • Herbert H. Engelhard

   Topic Review 02 August 2015 Pages: 1 - 7

   

2. A systematic review of cognitive performance in patients with childhood craniopharyngioma

   • Jale Özyurt
   • Hermann L. Müller
   • Christiane M. Thiel

   Topic Review 14 September 2015 Pages: 9 - 21

   

3. A novel nanoparticle containing neuritin peptide with grp170 induces a CTL response to inhibit tumor growth

   • Bangqing Yuan
   • Hanchao Shen
   • Zhao Yang

   Laboratory Investigation 20 August 2015 Pages: 23 - 32

   

4. Detection of proneural/mesenchymal marker expression in glioblastoma: temporospatial dynamics and association with chromatin-modifying gene expression

   • Hideki Murata
   • Koji Yoshimoto
   • Koji Iihara

   Laboratory Investigation 14 August 2015 Pages: 33 - 41

   

5. miR-429 inhibits glioma invasion through BMK1 suppression

   • Weiyi Chen
   • Baogang Zhang
   • Xiaolong Li

   Laboratory Investigation 14 August 2015 Pages: 43 - 54

   

6. Reactive oxygen species production has a critical role in hypoxia-induced Stat3 activation and angiogenesis in human glioblastoma

   • Mi Ok Yu
   • Kyung-Jae Park
   • Shin-Hyuk Kang

   Laboratory Investigation 22 August 2015 Pages: 55 - 63

   

7. Ex vivo generation of dendritic cells from cryopreserved, post-induction chemotherapy, mobilized leukapheresis from pediatric patients with medulloblastoma

   • Smita K. Nair
   • Timothy Driscoll
   • Duane A. Mitchell

   Laboratory Investigation 27 August 2015 Pages: 65 - 74

   

8. CCND2, CTNNB1, DDX3X, GLI2, SMARCA4, MYC, MYCN, PTCH1, TP53, and MLL2 gene variants and risk of childhood medulloblastoma

   • Anna M. Dahlin
   • Mads V. Hollegaard
   • Beatrice Melin

   Laboratory Investigation Open access 20 August 2015 Pages: 75 - 78

9. Specific inhibition of mTOR pathway induces anti-proliferative effect and decreases the hormone secretion in cultured pituitary adenoma cells

   • Rong Xie
   • Wen-Qiang He
   • Yao Zhao

   Laboratory Investigation 22 August 2015 Pages: 79 - 89

   

10. Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics

    • Patrick-Denis St-Coeur
    • Julie J. Poitras
    • Pier Jr Morin

    Laboratory Investigation 28 August 2015 Pages: 91 - 102

    

11. High levels of polo-like kinase 1 and phosphorylated translationally controlled tumor protein indicate poor prognosis in neuroblastomas

    • Pramila Ramani
    • Rachel Nash
    • Chris Rogers

    Laboratory Investigation 29 August 2015 Pages: 103 - 111

    

12. Hugl-1 inhibits glioma cell growth in intracranial model

    • Xuejiao Liu
    • Dong Lu
    • Xiuping Zhou

    Laboratory Investigation 04 September 2015 Pages: 113 - 121

    

13. Phase I study of iniparib concurrent with monthly or continuous temozolomide dosing schedules in patients with newly diagnosed malignant gliomas

    • Jaishri O. Blakeley
    • Stuart A. Grossman
    • Xiaobu Ye

    Clinical Study 19 August 2015 Pages: 123 - 131

14. Methotrexate administration directly into the fourth ventricle in children with malignant fourth ventricular brain tumors: a pilot clinical trial

    • David I. Sandberg
    • Michael Rytting
    • Soumen Khatua

    Clinical Study Open access 09 August 2015 Pages: 133 - 141

    

15. Ischemic stroke in patients with gliomas at The University of Texas-M.D. Anderson Cancer Center

    • Carlos Kamiya-Matsuoka
    • David Cachia
    • Ivo W. Tremont-Lukats

    Clinical Study 14 August 2015 Pages: 143 - 148

    

16. Long-term risk of radionecrosis and imaging changes after stereotactic radiosurgery for brain metastases

    • Zachary A. Kohutek
    • Yoshiya Yamada
    • Kathryn Beal

    Clinical Study 26 August 2015 Pages: 149 - 156

    

17. Changes in functional MRI signals after 3D based radiotherapy of glioblastoma multiforme

    • Árpád Kovács
    • Miklós Emri
    • Imre Repa

    Clinical Study 19 August 2015 Pages: 157 - 166

    

18. The use of ¹⁸F-FDG PET to differentiate progressive disease from treatment induced necrosis in high grade glioma

    • J. W. Dankbaar
    • T. J. Snijders
    • B. De Keizer

    Clinical Study Open access 18 September 2015 Pages: 167 - 175

    

19. Delayed leukoencephalopathy of non-small cell lung cancer patients with brain metastases underwent whole brain radiation therapy

    • Xiaoling Zhong
    • Biao Huang
    • Hongjun Liu

    Clinical Study 15 August 2015 Pages: 177 - 181

    

20. Dynamic contrast enhanced T1 MRI perfusion differentiates pseudoprogression from recurrent glioblastoma

    • Alissa A. Thomas
    • Julio Arevalo-Perez
    • Robert J. Young

    Clinical Study 15 August 2015 Pages: 183 - 190

    

21. A phase II trial of tamoxifen and bortezomib in patients with recurrent malignant gliomas

    • Yazmín Odia
    • Teri N. Kreisl
    • Howard A. Fine

    Clinical Study 19 August 2015 Pages: 191 - 195

22. Incidence and spectrum of paraneoplastic neurological syndromes: single center study

    • Meena A. Kanikannan
    • Y. Sirisha
    • Rupam Borgohain

    Clinical Study 27 August 2015 Pages: 197 - 206

    

23. A multicenter study of anaplastic oligodendroglioma: the Korean Radiation Oncology Group Study 13–12

    • Hyun-Cheol Kang
    • Tosol Yu
    • In Ah Kim

    Clinical Study 04 September 2015 Pages: 207 - 215

    

24. Bipolar radiofrequency ablation for metastatic spinal tumors: an evolving paradigm in palliative care

    • Giovanni Grasso

    Letter to the Editor 06 August 2015 Pages: 217 - 218

25. Prevalence of hepatitis B virus in primary central nervous system lymphoma

    • G. Faivre
    • V. Thibault
    • A. Idbaih

    Letter to the Editor 14 August 2015 Pages: 219 - 221

26. Erratum to: Survival prediction in high-grade gliomas using CT perfusion imaging

    • Timothy Pok Chi Yeung
    • Yong Wang
    • The Project of Emilia-Romagna Region on Neuro-Oncology (PERNO) Study Group

    Erratum 29 September 2015 Pages: 223 - 224